Salesforce
CRM
Microsoft
MSFT
Apple
AAPL
Taylor Morrison Home
TMHC
KB Home
KBH
US Stock MarketDetailed Quotes
ADAP Adaptimmune Therapeutics
- 0.630
- -0.005-0.79%
Trading Dec 12 14:47 ET
161.21MMarket Cap-3.77P/E (TTM)
0.646High0.609Low1.66MVolume0.625Open0.635Pre Close1.05MTurnover0.95%Turnover RatioLossP/E (Static)255.88MShares2.05052wk High2.01P/B109.53MFloat Cap0.43052wk Low--Dividend TTM173.86MShs Float21.570Historical High--Div YieldTTM5.84%Amplitude0.420Historical Low0.630Avg Price1Lot Size
About Adaptimmune Therapeutics Company
Adaptimmune Therapeutics Plc is commercial-stage cell therapy company, which focuses on providing novel cell therapies to people with cancer. Its clinical pipeline includes Afami-cel, Lete-cel, and ADP-A2M4CD8. The company was founded by Bent K. Jakobsen, James Julian Noble, and Helena Katrina Tayton-Martin in 2008 and is headquartered in Abingdon, the United Kingdom.
Company Profile
SymbolADAP
Company NameAdaptimmune Therapeutics
Listing DateMay 6, 2015
Issue Price17.00
Founded2014
CEOMr. Adrian Rawcliffe
MarketNASDAQ
Employees449
Securities TypeDR
ADS Ratio1.0 : 6.0
Fiscal Year Ends12-31
Address60 Jubilee Avenue,Milton Park
CityAbingdon
ProvinceOxfordshire
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeOX14 4RX
Phone44-1235-430000
Websitehttp://www.adaptimmune.com
Company Executives
- Name
- Position
- Salary
- Adrian Rawcliffe
- Director and Chief Executive Officer
- 2.77M
- James J. Noble
- Chief Executive Officer and Director
- --
- Cintia Piccina
- Chief Commercial Officer
- --
- William C. Bertrand, Jr
- Chief Operating Officer
- 1.22M
- Dr. Helen Tayton-Martin, PhD
- Chief Business and Strategy Officer
- 1.18M
- John Lunger
- Chief Patient Supply Officer
- --
- Gavin Hilary James Wood
- Chief Financial Officer and Principal Accounting Officer
- 1.17M
- Dr. Joanna Brewer
- Chief Scientific Officer
- --
- Dr. Elliot Norry
- Chief Medical Officer
- 1.18M
- David M. Mott
- Chairman of the Board
- 174.83K
- Dr. Andrew R. Allen, M.D.,PhD
- Independent Director
- 83.50K
- John P. Furey
- Independent Director
- 117.25K
- Dr. Garry E. Menzel, PhD
- Independent Director
- 117.29K
- Dr. Ali Behbahani, M.B.A.,M.D.
- Independent Director
- 111.54K
- Lawrence M. Alleva
- Independent Director
- 128.80K
- Dr. Priti Hegde, PhD
- Independent Director
- 82.25K
- Dr. Kristen M. Hege, M.D.
- Independent Director
- 72.63K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
